Transocean’s stock headed lower in early Tuesday trading, after the oil services company said it expects to book impairment charges of more than $600 million for the sale of assets.
Vaxcyte Inc.’s stock soared 33% early Tuesday, after the vaccine maker reported positive results from an early-stage trial of its 31-valent pneumococcal conjugate vaccine candidate in adults aged 50 and older.